Passage Bio, Inc. (PASG)
4.65
-0.10
(-2.11%)
USD |
NASDAQ |
Sep 04, 16:00
4.68
+0.03
(+0.65%)
After-Hours: 20:00
Passage Bio Cash and Short Term Investments (Annual) : 46.30M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 46.30M |
| December 31, 2024 | 76.76M |
| December 31, 2023 | 114.29M |
| December 31, 2022 | 189.61M |
| Date | Value |
|---|---|
| December 31, 2021 | 315.77M |
| December 31, 2020 | 304.82M |
| December 31, 2019 | 158.87M |
| December 31, 2018 | 24.86M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ARS Pharmaceuticals, Inc. | 244.99M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Savara, Inc. | 235.70M |